History and mechanisms of oral tolerance

Seminars in Immunology

Volumn 30, Issue , 2017, Pages 3-11

  Rezende, Rafael M ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anergy; Clonal deletion; Gut mucosa; Oral tolerance; Regulatory T cells; Tolerogenic dendritic cells

Indexed keywords

ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; AUTOANTIGEN;

ANTIGEN PRESENTATION; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; GAMMA DELTA T LYMPHOCYTE; HISTORY; HUMAN; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; NONHUMAN; ORAL IMMUNOTHERAPY; ORAL TOLERANCE; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; AUTOIMMUNE DISEASE; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALLERGY AND IMMUNOLOGY; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNE TOLERANCE;

EID: 85026387740     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.07.004     Document Type: Review

References (158)

1. Billingham, R.E., Brent, L., Medawar, P.B., Actively acquired tolerance of foreign cells. Nature 172:4379 (1953), 603–606.
2. Burnet, M.F., The Clonal Selection Theory of Immunity. 1st ed., 1959, The Vanderbilt and Cambridge University Presses, Nashiville/London (200).
3. Vaz, N.M., Maia, L.C., Hanson, D.G., Lynch, J.M., Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J. Allergy Clin. Immunol. 60:2 (1977), 110–115.
4. Moog, F., The lining of the small intestine. Sci. Am. 245:5 (1981), 154–158 (160, 162 et passiom.).
5. Brandtzaeg, P., Development and basic mechanisms of human gut immunity. Nutr. Rev. 56:1 Pt 2 (1998), S5–S18.
6. Macfarlane, G.T., Macfarlane, S., Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. 32:Suppl. 222 (1997), 3–9.
7. Owen, R.D., Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:2651 (1945), 400–401.
8. .
9. Hasek, M., Parabiosis of birds during their embryonic development. Chekhoslovatskaia Biol. 2:1 (1953), 29–31.
10. Avrameas, S., Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol. Today 12:5 (1991), 154–159.
11. Kerlero de Rosbo, N., Milo, R., Lees, M.B., Burger, D., Bernard, C.C., Ben-Nun, A., Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:6 (1993), 2602–2608.
12. Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H.L., Hafler, D.A., Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:3 (1994), 973–984.
13. Lacroix-Desmazes, S., Kaveri, S.V., Mouthon, L., Ayouba, A., Malanchere, E., Coutinho, A., Kazatchkine, M.D., Self-reactive antibodies (natural autoantibodies) in healthy individuals. J. Immunol. Methods 216:1–2 (1998), 117–137.
14. Cohen, I.R., Young, D.B., Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 12:4 (1991), 105–110.
15. Modigliani, Y., Coutinho, A., Pereira, P., Le Douarin, N., Thomas-Vaslin, V., Burlen-Defranoux, O., Salaun, J., Bandeira, A., Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26:8 (1996), 1807–1815.
16. Sakaguchi, S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004), 531–562.
17. Wells, H.G., Osborne, T.B., The biological reactions of the vegetable proteins. J. Infect. Dis., 8, 1911, 66.
18. Filipp, G., von Boros, B., The induction of immunological tolerance by antigen feeding. The effect of thymectomy on orally induced tolerance. J. Allergy 39:3 (1967), 167–170.
19. Auerbach, R., Clark, S., Immunological tolerance: transmission from mother to offspring. Science 189:4205 (1975), 811–813.
20. David, M.F., Prevention of homocytotropic antibody formation and anaphylactic sensitization by prefeeding antigen. J. Allergy Clin. Immunol. 60:3 (1977), 180–187.
21. Thomas, H.C., Parrott, M.V., The induction of tolerance to a soluble protein antigen by oral administration. Immunology 27:4 (1974), 631–639.
22. Andre, C., Heremans, J.F., Vaerman, J.P., Cambiaso, C.L., A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J. Exp. Med. 142:6 (1975), 1509–1519.
23. Mowat, A.M., The regulation of immune responses to dietary protein antigens. Immunol. Today 8:3 (1987), 93–98.
24. Mowat, A.M., Strobel, S., Drummond, H.E., Ferguson, A., Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 45:1 (1982), 105–113.
25. Hanson, D.G., Miller, S.D., Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells. J. Immunol. 128:5 (1982), 2378–2381.
26. Faria, A.M., Weiner, H.L., Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73 (1999), 153–264.
27. Lider, O., Santos, L.M., Lee, C.S., Higgins, P.J., Weiner, H.L., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J. Immunol. 142:3 (1989), 748–752.
28. Miller, A., Lider, O., Roberts, A.B., Sporn, M.B., Weiner, H.L., Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. U. S. A. 89:1 (1992), 421–425.
29. Miller, A., al-Sabbagh, A., Santos, L.M., Das, M.P., Weiner, H.L., Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151:12 (1993), 7307–7315.
30. Santos, L.M., al-Sabbagh, A., Londono, A., Weiner, H.L., Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell. Immunol. 157:2 (1994), 439–447.
31. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., Weiner, H.L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:5176 (1994), 1237–1240.
32. Chen, Y., Inobe, J., Weiner, H.L., Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J. Immunol. 155:2 (1995), 910–916.
33. Xu-Amano, J., Aicher, W.K., Taguchi, T., Kiyono, H., McGhee, J.R., Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4:4 (1992), 433–445.
34. Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 299:5609 (2003), 1057–1061.
35. Shevach, E.M., Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:5 (2009), 636–645.
36. Mestecky, J., McGhee, J.R., Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40 (1987), 153–245.
37. van der Heijden, P.J., Stok, W., Bianchi, A.T., Contribution of immunoglobulin-secreting cells in the murine small intestine to the total ‘background’ immunoglobulin production. Immunology 62:4 (1987), 551–555.
38. Macpherson, A.J., McCoy, K.D., Johansen, F.E., Brandtzaeg, P., The immune geography of IgA induction and function. Mucosal Immunol. 1:1 (2008), 11–22.
39. Fujihashi, K., Dohi, T., Rennert, P.D., Yamamoto, M., Koga, T., Kiyono, H., McGhee, J.R., Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. U. S. A. 98:6 (2001), 3310–3315.
40. Spahn, T.W., Fontana, A., Faria, A.M., Slavin, A.J., Eugster, H.P., Zhang, X., Koni, P.A., Ruddle, N.H., Flavell, R.A., Rennert, P.D., Weiner, H.L., Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur. J. Immunol. 31:4 (2001), 1278–1287.
41. Spahn, T.W., Weiner, H.L., Rennert, P.D., Lugering, N., Fontana, A., Domschke, W., Kucharzik, T., Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32:4 (2002), 1109–1113.
42. Kraus, T.A., Brimnes, J., Muong, C., Liu, J.H., Moran, T.M., Tappenden, K.A., Boros, P., Mayer, L., Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J. Clin. Invest. 115:8 (2005), 2234–2243.
43. Chirdo, F.G., Millington, O.R., Beacock-Sharp, H., Mowat, A.M., Immunomodulatory dendritic cells in intestinal lamina propria. Eur. J. Immunol. 35:6 (2005), 1831–1840.
44. Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes, J.L., Berg, P.L., Davidsson, T., Powrie, F., Johansson-Lindbom, B., Agace, W.W., Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205:9 (2008), 2139–2149.
45. Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., Belkaid, Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:8 (2007), 1775–1785.
46. Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., Powrie, F., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:8 (2007), 1757–1764.
47. Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., Song, S.Y., Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:4 (2004), 527–538.
48. Forster, R., Davalos-Misslitz, A.C., Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8:5 (2008), 362–371.
49. Worbs, T., Bode, U., Yan, S., Hoffmann, M.W., Hintzen, G., Bernhardt, G., Forster, R., Pabst, O., Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203:3 (2006), 519–527.
50. Spahn, T.W., Herbst, H., Rennert, P.D., Lugering, N., Maaser, C., Kraft, M., Fontana, A., Weiner, H.L., Domschke, W., Kucharzik, T., Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am. J. Pathol. 161:6 (2002), 2273–2282.
51. Walker, W.A., Isselbacher, K.J., Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology 67:3 (1974), 531–550.
52. Husby, S., Jensenius, J.C., Svehag, S.E., Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand. J. Immunol. 22:1 (1985), 83–92.
53. Smith, K.M., Davidson, J.M., Garside, P., T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 106:2 (2002), 144–158.
54. Zinselmeyer, B.H., Dempster, J., Gurney, A.M., Wokosin, D., Miller, M., Ho, H., Millington, O.R., Smith, K.M., Rush, C.M., Parker, I., Cahalan, M., Brewer, J.M., Garside, P., In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J. Exp. Med. 201:11 (2005), 1815–1823.
55. Peng, H.J., Turner, M.W., Strobel, S., The generation of a ‘tolerogen’ after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81:3 (1990), 510–515.
56. Thomson, A.W., Knolle, P.A., Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10:11 (2010), 753–766.
57. Peng, R.Y., Wang, D.W., Xu, Z.H., Gao, Y.B., Yang, R.B., Liu, P., Wang, Z.P., Li, Y.P., The changes and significance of mast cells in irradiated rat liver. J. Environ. Pathol. Toxicol. Oncol. 13:2 (1994), 111–116.
58. Callery, M.P., Kamei, T., Flye, M.W., The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J. Surg. Res. 46:4 (1989), 391–394.
59. Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G., Kaiserlian, D., Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29:3 (2008), 464–475.
60. Faria, A.M.C., Maron, R., Ficker, S.M., Slavin, A.J., Spahn, T., Weiner, H.L., Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 20:2 (2003), 135–145.
61. Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E., Hafler, D.A., Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12 (1994), 809–837.
62. Ngan, J., Kind, L.S., Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol. 120:3 (1978), 861–865.
63. Afuwape, A.O., Turner, M.W., Strobel, S., Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent. Clin. Exp. Immunol. 136:1 (2004), 40–48.
64. Nakamura, K., Kitani, A., Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:5 (2001), 629–644.
65. Oida, T., Zhang, X., Goto, M., Hachimura, S., Totsuka, M., Kaminogawa, S., Weiner, H.L., CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J. Immunol. 170:5 (2003), 2516–2522.
66. Chen, M.L., Yan, B.S., Bando, Y., Kuchroo, V.K., Weiner, H.L., Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J. Immunol. 180:11 (2008), 7327–7337.
67. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V.K., Weiner, H.L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:6536 (1995), 177–180.
68. Marth, T., Strober, W., Kelsall, B.L., High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J. Immunol. 157:6 (1996), 2348–2357.
69. Marth, T., Zeitz, M., Ludviksson, B.R., Strober, W., Kelsall, B.L., Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J. Immunol. 162:12 (1999), 7233–7240.
70. Meyer, A.L., Benson, J., Song, F., Javed, N., Gienapp, I.E., Goverman, J., Brabb, T.A., Hood, L., Whitacre, C.C., Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein. J. Immunol. 166:9 (2001), 5773–5781.
71. Garside, P., Steel, M., Worthey, E.A., Kewin, P.J., Howie, S.E., Harrison, D.J., Bishop, D., Mowat, A.M., Lymphocytes from orally tolerized mice display enhanced susceptibility to death by apoptosis when cultured in the absence of antigen in vitro. Am. J. Pathol. 149:6 (1996), 1971–1979.
72. Kaji, T., Hachimura, S., Ise, W., Kaminogawa, S., Proteome analysis reveals caspase activation in hyporesponsive CD4 T lymphocytes induced in vivo by the oral administration of antigen. J. Biol. Chem. 278:30 (2003), 27836–27843.
73. Kearney, E.R., Pape, K.A., Loh, D.Y., Jenkins, M.K., Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:4 (1994), 327–339.
74. Chen, Y., Inobe, J., Weiner, H.L., Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol. 178:1 (1997), 62–68.
75. Gutgemann, I., Fahrer, A.M., Altman, J.D., Davis, M.M., Chien, Y.H., Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8:6 (1998), 667–673.
76. Van Houten, N., Blake, S.F., Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 157:4 (1996), 1337–1341.
77. Neurath, M.F., Finotto, S., Fuss, I., Boirivant, M., Galle, P.R., Strober, W., Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol. 22:1 (2001), 21–26.
78. Miller, M.L., Cowdery, J.S., Laskin, C.A., Curtin, M.F. Jr., Steinberg, A.D., Heterogeneity of oral tolerance defects in autoimmune mice. Clin. Immunol. Immunopathol. 31:2 (1984), 231–240.
79. Freire-de-Lima, C.G., Nascimento, D.O., Soares, M.B., Bozza, P.T., Castro-Faria-Neto, H.C., de Mello, F.G., DosReis, G.A., Lopes, M.F., Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403:6766 (2000), 199–203.
80. Chen, W., Jin, W., Tian, H., Sicurello, P., Frank, M., Orenstein, J.M., Wahl, S.M., Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J. Exp. Med. 194:4 (2001), 439–453.
81. Ramachandran, A., Madesh, M., Balasubramanian, K.A., Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions. J. Gastroenterol. Hepatol. 15:2 (2000), 109–120.
82. Boirivant, M., Pica, R., DeMaria, R., Testi, R., Pallone, F., Strober, W., Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J. Clin. Invest. 98:11 (1996), 2616–2622.
83. Huang, F.P., Platt, N., Wykes, M., Major, J.R., Powell, T.J., Jenkins, C.D., MacPherson, G.G., A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:3 (2000), 435–444.
84. Fadok, V.A., Bratton, D.L., Konowal, A., Freed, P.W., Westcott, J.Y., Henson, P.M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:4 (1998), 890–898.
85. Paul, W.E., Seder, R.A., Lymphocyte responses and cytokines. Cell 76:2 (1994), 241–251.
86. Weiner, H.L., The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat. Immunol. 2:8 (2001), 671–672.
87. Horwitz, D.A., Zheng, S.G., Gray, J.D., The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J. Leukoc. Biol. 74:4 (2003), 471–478.
88. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., Wahl, S.M., Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:12 (2003), 1875–1886.
89. Macian, F., Garcia-Cozar, F., Im, S.H., Horton, H.F., Byrne, M.C., Rao, A., Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109:6 (2002), 719–731.
90. Kriegel, M.A., Rathinam, C., Flavell, R.A., E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance. Proc. Natl. Acad. Sci. U. S. A. 106:39 (2009), 16770–16775.
91. Ise, W., Nakamura, K., Shimizu, N., Goto, H., Fujimoto, K., Kaminogawa, S., Hachimura, S., Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation. J. Immunol. 175:2 (2005), 829–838.
92. Whitacre, C.C., Gienapp, I.E., Orosz, C.G., Bitar, D.M., Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147:7 (1991), 2155–2163.
93. Melamed, D., Friedman, A., Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23:4 (1993), 935–942.
94. Friedman, A., Weiner, H.L., Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. U. S. A. 91:14 (1994), 6688–6692.
95. Melamed, D., Friedman, A., In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur. J. Immunol. 24:9 (1994), 1974–1981.
96. Hirahara, K., Hisatsune, T., Nishijima, K., Kato, H., Shiho, O., Kaminogawa, S., CD4+ T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice. J. Immunol. 154:12 (1995), 6238–6245.
97. Inada, S., Yoshino, S., Haque, M.A., Ogata, Y., Kohashi, O., Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen. Cell. Immunol. 175:1 (1997), 67–75.
98. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., Sakaguchi, S., Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:12 (1998), 1969–1980.
99. Gavin, M.A., Clarke, S.R., Negrou, E., Gallegos, A., Rudensky, A., Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:1 (2002), 33–41.
100. Tsuji, N.M., Mizumachi, K., Kurisaki, J., CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Int. Immunol. 15:4 (2003), 525–534.
101. Mannie, M.D., Rendall, S.K., Arnold, P.Y., Nardella, J.P., White, G.A., Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 157:3 (1996), 1062–1070.
102. Taams, L.S., van Rensen, A.J., Poelen, M.C., van Els, C.A., Besseling, A.C., Wagenaar, J.P., van Eden, W., Wauben, M.H., Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 28:9 (1998), 2902–2912.
103. Lanoue, A., Bona, C., von Boehmer, H., Sarukhan, A., Conditions that induce tolerance in mature CD4+ T cells. J. Exp. Med. 185:3 (1997), 405–414.
104. Ryan, K.R., Evavold, B.D., Persistence of peptide-induced CD4+ T cell anergy in vitro. J. Exp. Med. 187:1 (1998), 89–96.
105. Lombardi, G., Arnold, K., Uren, J., Marelli-Berg, F., Hargreaves, R., Imami, N., Weetman, A., Lechler, R., Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur. J. Immunol. 27:1 (1997), 62–71.
106. Cauley, L.S., Cauley, K.A., Shub, F., Huston, G., Swain, S.L., Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma. J. Exp. Med. 186:1 (1997), 71–81.
107. Thornton, A.M., Shevach, E.M., CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:2 (1998), 287–296.
108. Hoyne, G.F., Lamb, J.R., Regulation of T cell function in mucosal tolerance. Immunol. Cell Biol. 75:2 (1997), 197–201.
109. Nishizuka, Y., Sakakura, T., Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:3906 (1969), 753–755.
110. Kojima, A., Tanaka-Kojima, Y., Sakakura, T., Nishizuka, Y., Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest. 34:6 (1976), 550–557.
111. Fukuma, K., Sakaguchi, S., Kuribayashi, K., Chen, W.L., Morishita, R., Sekita, K., Uchino, H., Masuda, T., Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. Gastroenterology 94:2 (1988), 274–283.
112. Sakaguchi, S., Takahashi, T., Nishizuka, Y., Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 156:6 (1982), 1565–1576.
113. Sakaguchi, S., Takahashi, T., Nishizuka, Y., Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156:6 (1982), 1577–1586.
114. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:3 (1995), 1151–1164.
115. Ramsdell, F., Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity 19:2 (2003), 165–168.
116. Sakaguchi, S., Powrie, F., Emerging challenges in regulatory T cell function and biology. Science 317:5838 (2007), 627–629.
117. Tadokoro, C.E., Shakhar, G., Shen, S., Ding, Y., Lino, A.C., Maraver, A., Lafaille, J.J., Dustin, M.L., Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203:3 (2006), 505–511.
118. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J.J., Curotto de Lafaille, M.A., Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115:7 (2005), 1923–1933.
119. Kim, K.S., Hong, S.W., Han, D., Yi, J., Jung, J., Yang, B.G., Lee, J.Y., Lee, M., Surh, C.D., Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351:6275 (2016), 858–863.
120. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., Cheroutre, H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:5835 (2007), 256–260.
121. Hirano, T., Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16:3–4 (1998), 249–284.
122. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:7090 (2006), 235–238.
123. Weiner, H.L., Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3:11 (2001), 947–954.
124. Ochi, H., Abraham, M., Ishikawa, H., Frenkel, D., Yang, K., Basso, A.S., Wu, H., Chen, M.-L., Gandhi, R., Miller, A., Maron, R., Weiner, H.L., Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25-LAP+ T cells. Nat. Med. 12:6 (2006), 627–635.
125. da Cunha, A.P., Wu, H.Y., Rezende, R.M., Vandeventer, T., Weiner, H.L., In vivo anti-LAP mAb enhances IL-17/IFN-gamma responses and abrogates anti-CD3-induced oral tolerance. Int. Immunol. 27:2 (2015), 73–82.
126. Ishikawa, H., Ochi, H., Chen, M.L., Frenkel, D., Maron, R., Weiner, H.L., Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes 56:8 (2007), 2103–2109.
127. Bevier, W.C., Trujillo, A.L., Primbs, G.B., Bradley, M.K., Jovanovic, L., Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring—a preliminary report. Diabetes Metab. Res. Rev. 27:5 (2011), 480–487.
128. Hu, C., Ding, H., Zhang, X., Wong, F.S., Wen, L., Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes. Diabetes 62:8 (2013), 2849–2858.
129. Ilan, Y., Maron, R., Tukpah, A.M., Maioli, T.U., Murugaiyan, G., Yang, K., Wu, H.Y., Weiner, H.L., Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc. Natl. Acad. Sci. U. S. A. 107:21 (2010), 9765–9770.
130. Wu, H.Y., Center, E.M., Tsokos, G.C., Weiner, H.L., Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells. Lupus 18:7 (2009), 586–596.
131. Sasaki, N., Yamashita, T., Takeda, M., Shinohara, M., Nakajima, K., Tawa, H., Usui, T., Hirata, K., Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 120:20 (2009), 1996–2005.
132. Weiner, H.L., da Cunha, A.P., Quintana, F., Wu, H., Oral tolerance. Immunol. Rev. 241:1 (2011), 241–259.
133. Gregori, S., Goudy, K.S., Roncarolo, M.G., The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front. Immunol., 3, 2012, 30.
134. Gregori, S., Passerini, L., Roncarolo, M.G., Clinical outlook for type-1 and FOXP3(+) T regulatory cell-based therapy. Front. Immunol., 6, 2015, 593.
135. Wu, H.Y., Quintana, F.J., da Cunha, A.P., Dake, B.T., Koeglsperger, T., Starossom, S.C., Weiner, H.L., In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One, 6(8), 2011, e23618.
136. Mayo, L., Cunha, A.P., Madi, A., Beynon, V., Yang, Z., Alvarez, J.I., Prat, A., Sobel, R.A., Kobzik, L., Lassmann, H., Quintana, F.J., Weiner, H.L., IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain 139:Pt 7 (2016), 1939–1957.
137. Girardi, M., Immunosurveillance and immunoregulation by gammadelta T cells. J. Invest. Dermatol. 126:1 (2006), 25–31.
138. Vantourout, P., Hayday, A., Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat. Rev. Immunol. 13:2 (2013), 88–100.
139. Wesch, D., Peters, C., Oberg, H.H., Pietschmann, K., Kabelitz, D., Modulation of gammadelta T cell responses by TLR ligands. Cell. Mol. Life Sci. 68:14 (2011), 2357–2370.
140. Inagaki-Ohara, K., Chinen, T., Matsuzaki, G., Sasaki, A., Sakamoto, Y., Hiromatsu, K., Nakamura-Uchiyama, F., Nawa, Y., Yoshimura, A., Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J. Immunol. 173:2 (2004), 1390–1398.
141. Chen, Y., Chou, K., Fuchs, E., Havran, W.L., Boismenu, R., Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc. Natl. Acad. Sci. U. S. A. 99:22 (2002), 14338–14343.
142. Mielke, L.A., Jones, S.A., Raverdeau, M., Higgs, R., Stefanska, A., Groom, J.R., Misiak, A., Dungan, L.S., Sutton, C.E., Streubel, G., Bracken, A.P., Mills, K.H., Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210:6 (2013), 1117–1124.
143. Jeong, S.P., Kang, J.A., Park, S.G., Intestinal intraepithelial TCRgammadelta(+) T cells are activated by normal commensal bacteria. J. Microbiol. 50:5 (2012), 837–841.
144. Rezende, R.M., da Cunha, A.P., Kuhn, C., Rubino, S., M'Hamdi, H., Gabriely, G., Vandeventer, T., Liu, S., Cialic, R., Pinheiro-Rosa, N., Oliveira, R.P., Gaublomme, J.T., Obholzer, N., Kozubek, J., Pochet, N., Faria, A.M., Weiner, H.L., Identification and characterization of latency-associated peptide-expressing gammadelta T cells. Nat. Commun., 6, 2015, 8726.
145. Mengel, J., Cardillo, F., Aroeira, L.S., Williams, O., Russo, M., Vaz, N.M., Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48:2 (1995), 97–102.
146. Fujihashi, K., Dohi, T., Kweon, M.N., McGhee, J.R., Koga, T., Cooper, M.D., Tonegawa, S., Kiyono, H., gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int. Immunol. 11:12 (1999), 1907–1916.
147. Kagnoff, M.F., Effects of antigen-feeding on intestinal and systemic immune responses. III. Antigen-specific serum-mediated suppression of humoral antibody responses after antigen feeding. Cell. Immunol. 40:1 (1978), 186–203.
148. Chalon, M.P., Milne, R.W., Vaerman, J.P., In vitro immunosuppressive effect of serum from orally immunized mice. Eur. J. Immunol. 9:10 (1979), 747–751.
149. Bhogal, B.S., Karkhanis, Y.D., Bell, M.K., Sanchez, P., Zemcik, B., Siskind, G.W., Thorbecke, G.J., Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B-cell tolerance in rabbits after feeding antigen. Cell. Immunol. 101:1 (1986), 93–104.
150. Sato, S., Qian, J.H., Kokudo, S., Ikegami, R., Suda, T., Hamaoka, T., Fujiwara, H., Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route. J. Immunol. 140:3 (1988), 717–722.
151. Hanson, D.G., Vaz, N.M., Maia, L.C., Lynch, J.M., Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin by orally induced antibodies. J. Immunol. 123:5 (1979), 2337–2343.
152. Jarrett, E.E., Hall, E., The development of IgE-suppressive immunocompetence in young animals: influence of exposure to antigen in the presence or absence of maternal immunity. Immunology 53:2 (1984), 365–373.
153. de Weerd, N., Bhalla, P.L., Singh, M.B., Oral immunization with a recombinant major grass pollen allergen induces blocking antibodies in mice. Int. Arch. Allergy Immunol. 130:2 (2003), 119–124.
154. Clark, A.T., Islam, S., King, Y., Deighton, J., Anagnostou, K., Ewan, P.W., Successful oral tolerance induction in severe peanut allergy. Allergy 64:8 (2009), 1218–1220.
155. Varshney, P., Jones, S.M., Scurlock, A.M., Perry, T.T., Kemper, A., Steele, P., Hiegel, A., Kamilaris, J., Carlisle, S., Yue, X., Kulis, M., Pons, L., Vickery, B., Burks, A.W., A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J. Allergy Clin. Immunol. 127:3 (2011), 654–660.
156. Halota, W., Ferenci, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., Ilan, Y., Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial. J. Viral Hepat. 22:8 (2015), 651–657.
157. Lalazar, G., Mizrahi, M., Turgeman, I., Adar, T., Ben Ya'acov, A., Shabat, Y., Nimer, A., Hemed, N., Zolotarovya, L., Lichtenstein, Y., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., Ilan, Y., Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo-controlled trial. J. Clin. Immunol. 35:4 (2015), 399–407.
158. Sherman, A., Su, J., Lin, S., Wang, X., Herzog, R.W., Daniell, H., Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 124:10 (2014), 1659–1668.